Javascript must be enabled to continue!
Brief of Professor Laura K. Donohue as Amicus Curiae in Support of Neither Party, FBI v. Fazaga, No. 20-828
View through CrossRef
Amicus submits this brief in support of neither party to provide the Court with background on the origins and evolution of the state-secrets privilege. The English and American cases decided before United States v. Reynolds, 345 U.S. 1 (1953), as well as the decisions before and after the enactment of the Foreign Intelligence Surveillance Act of 1978 (FISA), produce several observations that may help the Court to resolve this case.<br><br>First, both Reynolds and earlier English and American case law treat state secrets as an evidentiary privilege rather than a substantive rule of decision. As with other privileges, upholding an assertion of state secrets means that the case should continue, if possible, without the privileged information. Totten v. United States, 92 U.S. 105 (1876), in contrast, states a different rule of narrow applicability resting on the secrecy inherent in certain government contracts, as the Court made clear in General Dynamics Corp. v. United States, 563 U.S. 478, 485, 490 (2011), and Tenet v. Doe, 544 U.S. 1, 9-10 (2005).<br><br>Second, although the judiciary affords the executive branch deference in asserting state secrets, courts consistently acknowledge their own, critical role in ensuring that those invocations of privilege are justified.<br><br>Third, courts strive to find ways to avoid dismissing cases whenever possible. Often that means using in camera procedures to evaluate a defense, as in then-Judge Scalia’s opinion in Molerio v. FBI, 749 F.2d 815, 822 (D.C. Cir. 1984).<br><br>Fourth, although dismissal based on the state-secrets evidentiary privilege finds no support in early English or U.S. cases before FISA (outside of the inapposite Totten line), a few post-FISA decisions have dismissed lawsuits regardless of their merits on the grounds that further litigation presents too great a risk of exposing state secrets. Those decisions underscore how rare that severe result should be. And they are confined primarily to circumstances in which state secrets are central, such as extraordinary rendition or defamation, where the truth or falsity of statements.
Title: Brief of Professor Laura K. Donohue as Amicus Curiae in Support of Neither Party, FBI v. Fazaga, No. 20-828
Description:
Amicus submits this brief in support of neither party to provide the Court with background on the origins and evolution of the state-secrets privilege.
The English and American cases decided before United States v.
Reynolds, 345 U.
S.
1 (1953), as well as the decisions before and after the enactment of the Foreign Intelligence Surveillance Act of 1978 (FISA), produce several observations that may help the Court to resolve this case.
<br><br>First, both Reynolds and earlier English and American case law treat state secrets as an evidentiary privilege rather than a substantive rule of decision.
As with other privileges, upholding an assertion of state secrets means that the case should continue, if possible, without the privileged information.
Totten v.
United States, 92 U.
S.
105 (1876), in contrast, states a different rule of narrow applicability resting on the secrecy inherent in certain government contracts, as the Court made clear in General Dynamics Corp.
v.
United States, 563 U.
S.
478, 485, 490 (2011), and Tenet v.
Doe, 544 U.
S.
1, 9-10 (2005).
<br><br>Second, although the judiciary affords the executive branch deference in asserting state secrets, courts consistently acknowledge their own, critical role in ensuring that those invocations of privilege are justified.
<br><br>Third, courts strive to find ways to avoid dismissing cases whenever possible.
Often that means using in camera procedures to evaluate a defense, as in then-Judge Scalia’s opinion in Molerio v.
FBI, 749 F.
2d 815, 822 (D.
C.
Cir.
1984).
<br><br>Fourth, although dismissal based on the state-secrets evidentiary privilege finds no support in early English or U.
S.
cases before FISA (outside of the inapposite Totten line), a few post-FISA decisions have dismissed lawsuits regardless of their merits on the grounds that further litigation presents too great a risk of exposing state secrets.
Those decisions underscore how rare that severe result should be.
And they are confined primarily to circumstances in which state secrets are central, such as extraordinary rendition or defamation, where the truth or falsity of statements.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Pengaruh Amicus Curiae (Sahabat Pengadilan) dalam Mempengaruhi Putusan Hakim menurut Sistem Peradilan Pidana
Pengaruh Amicus Curiae (Sahabat Pengadilan) dalam Mempengaruhi Putusan Hakim menurut Sistem Peradilan Pidana
Abstract. This research focuses on the regulation of Amicus Curiae in criminal procedural law in Indonesia and the influence of Amicus Curiae on judges' decisions in criminal justi...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Profesor Stanisław Batawia
Profesor Stanisław Batawia
The editor-in-chief of „Archiwum Kryminologii”, professor Stanisław Batawia, full member of the Polish Academy of Sciences, Professor of Warsaw University and of the Institute of ...
KEDUDUKAN AMICUS CURIAE DALAM KASUS RICHARD ELIEZER PADA KETENTUAN PASAL 5 AYAT 1 UU NO. 48 TAHUN 2009 TENTANG KEKUASAAN KEHAKIMAN
KEDUDUKAN AMICUS CURIAE DALAM KASUS RICHARD ELIEZER PADA KETENTUAN PASAL 5 AYAT 1 UU NO. 48 TAHUN 2009 TENTANG KEKUASAAN KEHAKIMAN
Pembuktian Ini membuktikan bahwa ia memainkan peran penting dalam hukum pidana, karena pada dasarnya dimulai pada saat insiden hukum yang diketahui. Menurut hukum, bukti dibatasi m...
Amicus Curiae Institute in the Constitutional Process
Amicus Curiae Institute in the Constitutional Process
Given the specifics of constitutional proceedings, the question of the peculiarities of evidence in a constitutional trial is becoming increasingly important. With the adoption of ...

